Envoy Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $241,000 | $225,000 | $316,000 | $237,000 | — |
| Operating income | -$22.3M | -$19.3M | -$18.4M | -$8.7M | -$5.2M |
| Cost of revenue | $874,000 | $742,000 | $789,000 | $498,000 | — |
| Cash from operations | -$18.2M | -$17.9M | -$17.1M | -$8.8M | -$3.2M |
| Capital expenditure | $179,000 | $980,000 | $153,000 | $218,000 | — |
| Free cash flow | -$18.4M | -$18.9M | -$17.2M | -$9.0M | — |
| Impairments | — | $0 | — | — | — |
| Total assets | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M |
| Total liabilities | $20.3M | $30.4M | $10.0M | $38.8M | $38.6M |
Shares outstanding 76.9M · Free float 56.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.